These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3055408)

  • 1. [Pre- and post-marketing management of side effects of drugs. Application to antidepressive agents].
    Auriche M
    Therapie; 1988; 43(4):299-306. PubMed ID: 3055408
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacovigilance and 2nd generation antidepressive agents].
    Guelfi JD
    Encephale; 1991; 17 Spec No 1():139-44. PubMed ID: 1864261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-marketing surveillance of drugs: epidemiologic approach].
    Stanulović M; Jakovljević V; Sabo A
    Med Pregl; 1987; 40(11-12):573-7. PubMed ID: 3331415
    [No Abstract]   [Full Text] [Related]  

  • 4. Contraceptive development and clinical trials.
    Fraser IS
    Clin Reprod Fertil; 1986 Feb; 4(1):75-85. PubMed ID: 3708511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug surveillance. Monitoring the side-effects of drugs in the post-marketing phase: cimetidine. II].
    Mariani L; Minora T
    Clin Ter; 1984 Apr; 109(2):109-25. PubMed ID: 6234121
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacovigilance as new direction of research].
    Gaszner G; Makkos Z; Gaszner P
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hematologic toxicity of antidepressive agents].
    Galbaud du Fort G
    Encephale; 1988; 14(4):307-18. PubMed ID: 3058454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs: watch out for unexpected adverse effects.
    Prescrire Int; 2002 Oct; 11(61):150-1. PubMed ID: 12378747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of roentgen contrast medium reactions after intravenous injection in pre-registration trials and post-marketing surveillances.
    Andrew E; Haider T
    Acta Radiol; 1993 May; 34(3):210-3. PubMed ID: 8489831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levofloxacin adverse effects, data from clinical trials and pharmacovigilance].
    Carbon C
    Therapie; 2001; 56(1):35-40. PubMed ID: 11322015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
    Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program.
    Singh G
    J Rheumatol; 2001 May; 28(5):1174-9. PubMed ID: 11361209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase IV research. Antidepressive agents in neurologic practice].
    Linden M
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1987; 49():1-160. PubMed ID: 3323896
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mandatory post marketing studies.
    Somberg J
    Am J Ther; 2007; 14(4):321. PubMed ID: 17667203
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary clinical results of a new non tricyclic antidepressive drug: oxaflozane].
    Rascol A; Maurel H; David J; Layani M
    Therapie; 1974; 29(1):95-9. PubMed ID: 4603757
    [No Abstract]   [Full Text] [Related]  

  • 17. Post marketing surveillance. Traps for the unwary.
    Marley J; Mant A
    Aust Fam Physician; 1993 Jun; 22(6):1009-11, 1013. PubMed ID: 8338446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk-benefit ratio of drugs. Antidepressive agents as an example].
    Girard M
    Encephale; 1988; 14(3):97-9. PubMed ID: 3402382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for human data: the role of clinical trials and postmarketing surveillance in the safety assessment of macronutrient substitutes.
    Forbes AL
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S20-1; discussion S31-7. PubMed ID: 8801611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacovigilance of new antidepressants: evaluation of neuro-psychobehavioral disorders].
    Blayac JP; Hillaire-Buys D; Peyrière H
    Therapie; 1997; 52(2):117-22. PubMed ID: 9231505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.